HoxA7 Antibodies

Santa Cruz Biotechnology offers a broad range of HoxA7 monoclonal antibodies for advanced research in developmental biology and gene regulation. HoxA7 monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). HoxA7 is a member of the homeobox gene family, which plays a critical role in regulating embryonic development and cell differentiation. HoxA7 contributes to the establishment of body plans and the formation of specific tissues and organs. Dysregulation of HoxA7 has been implicated in various cancers, making it a significant target for therapeutic research. Understanding HoxA7's role in development and disease progression can lead to breakthroughs in cancer research and therapeutic strategies. Investigating HoxA7's functions in cellular processes helps reveal its impact on gene expression and developmental pathways. Research with HoxA7 monoclonal antibodies advances knowledge about embryonic development, tissue formation, and disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of developmental biology and disease pathways.